Human T‐cell lymphotropic virus (HTLV) types I and II were the first discovered human
retroviruses. While HTLV‐I has been clearly associated with disease, the health implications …

Human T-lymphotropic virus type III (HTLV-III) is a recently discovered retrovirus with tropism
and cytotoxicity for the OKT4+ lymphocytes that are depleted in the acquired immune …

Human T-lymphotropic virus type I (HTLV-I) and HTLV-II have been postulated to accelerate
disease progression in patients coinfected with HIV. However, recent evidence suggests that …

Human immunodeficiency virus (HIV) and human T‐cell lymphotropic virus (HTLV) are both
retroviruses with similar routes of transmission. A number of reports suggest variable clinical …

Human T-lymphotropic virus type II (HTLV-II) is a human retrovirus which is endemic in
Amerindian and pygmy tribes. Molecular subtypes show geographic segregation consistent …

Several reports suggest that HTLV-I/HIV coinfection may be associated with an increased
risk of HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP). In HTLV-I …

Introduction Human T-lymphotropic virus type 1 or 2 (HTLV-1/2) co-infection in patients
infected with the human immunodeficiency virus (HIV) can lead to increased morbidity …

The third member of the human T-cell leukemia (lymphotrophic) retrovirus family (HTLV-III) is
a newly discovered retrovirus that has been closely associated with the acquired …

The goal of this study was to investigate clinical outcomes and survival probabilities among
persons coinfected with human immunodeficiency virus (HIV) and human T lymphotropic …

Human T lymphotropic viruses (HTLVs) have a limited spread in the general populations of
Western countries. Consequently, the transfusional risk for HTLV is considered to be low in …